Twist Bioscience Corporation TWST
Updated: 11 Aug 2026
No signal published yet
We already track Twist Bioscience and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Twist Bioscience Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Twist Bioscience free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 3, 2026, Twist Bioscience reported record revenue of $118.4 million for the third quarter of fiscal 2026, up 23% year-over-year, and raised its full-year revenue guidance to between $456 million and $457 million. Shortly after, on August 5, 2026, the company announced the pricing of an upsized $300 million public offering of common stock.
What Firelda Watch includes for Twist Bioscience Corporation
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Twist Bioscience Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Twist Bioscience free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more